5th World Congress on Cardiovascular Medicine Pharmacology (Cardiovascular 2025)

5th-World-Congress-on-Cardiovascular-Medicine-Pharmacology-(Cardiovascular-2025)

The 5th World Congress on Cardiovascular Medicine Pharmacology, scheduled for July 24-25, 2025 in Paris, France, invites experts, researchers, and clinicians to explore the latest breakthroughs in the pharmacological treatment of cardiovascular diseases. Under the theme “Targeting Cardiovascular Disease: Pharmacological Frontiers,” the conference will highlight innovative therapies, novel drug targets, and cutting-edge research in the field.

As cardiovascular diseases continue to be a leading cause of morbidity and mortality globally, the event will focus on advancing pharmacological strategies to improve prevention, diagnosis, and treatment. Attendees will gain insights into emerging drug classes, personalized medicine, and the role of pharmacogenomics in optimizing cardiovascular care. This international gathering will provide a platform for collaboration, knowledge exchange, and discussions on the future of cardiovascular pharmacology, with a focus on precision medicine, safety, and innovative drug development. Join us in Paris to be part of shaping the future of cardiovascular health.

Scientific Sessions

Track 1:Advances in Cardiovascular Drug Discovery
Track 2:Molecular Mechanisms of Cardiovascular Pharmacology
Track 3:Novel Targets in Hypertension Therapy
Track 4:Pharmacogenomics in Cardiovascular Medicine
Track 5:Cardiac Arrhythmias and Pharmacotherapy
Track 6:Emerging Antithrombotic Therapies
Track 7:Role of Inflammation in Cardiovascular Diseases
Track 8:Drug Repurposing in Cardiovascular Medicine
Track 9:Pharmacokinetics and Pharmacodynamics in Cardiology
Track 10:Vascular Pharmacology: Focus on Endothelial Dysfunction
Track 11:Innovations in Heart Failure Pharmacotherapy
Track 12:Lipids and Cholesterol Management in Cardiovascular Disease
Track 13:Targeted Therapies in Cardiovascular Regeneration
Track 14:Pharmacological Management of Cardiovascular Risk Factors
Track 15:Endothelial Nitric Oxide and Cardiovascular Health
Track 16:Cardiovascular Drug Safety and Toxicology
Track 17:Targeting the Renin-Angiotensin-Aldosterone System (RAAS)
Track 18:Pharmacological Approaches to Myocardial Ischemia
Track 19:Biomarkers in Cardiovascular Disease and Drug Response
Track 20:Cardiovascular Pharmacology in Special Populations
Track 21:Cardio protective Agents: Mechanisms and Applications
Track 22:Personalized Medicine in Cardiovascular Care
Track 23:Nanomedicine in Cardiovascular Pharmacology
Track 24:Role of Gut Microbiome in Cardiovascular Health

Important Dates
Date formats: d/m/y
Event Details
Leave a Comment

Event Details